Pharmacy chain CVS has stepped up its drive into the wider healthcare market with an agreement to buy at-home care and technology provider Signify Health for around $8 billion – reportedly
It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
